Treatment of severe acute graft-versus-host disease with third party haploidentical mesenchymal stem cells

Koç, 2000, Rapid hematopoietic recovery after coinfusion of autologous-blood stem cells and culture-expanded marrow mesenchymal stem cells in advanced breast cancer patients receiving high-dose chemotherapy, J Clin Oncol, 18, 307, 10.1200/JCO.2000.18.2.307

Frassoni, 2002, Expanded mesenchymal stem cells (MSC), co-infused with HLA identical hematopoietic stem cell transplants, reduce acute and chronic graft-versus-host disease: a matched pair analysis, Bone Marrow Transplant, 29, S2

Le Blanc, 2003, Mesenchymal stem cells inhibit and stimulate mixed lymphocyte cultures and mitogenic responses independently of the major histocompatibility system, Scand J Immunol, 57, 11, 10.1046/j.1365-3083.2003.01176.x

Uzunel, 2001, The significance of graft-versus-host disease and pretransplant minimal residual disease status to outcome after allogeneic stem cell transplantation in patients with acute lymphoblastic leukemia, Blood, 98, 1982, 10.1182/blood.V98.6.1982

Denne, 2003, Mesenchymal stem cells distribute to a wide range of tissues following systemic infusion into nonhuman primates, Blood, 101, 2999, 10.1182/blood-2002-06-1830